Orthopaedic Research Center Amsterdam, Academic Medical Center, Department of Orthopaedic Surgery, Amsterdam, the Netherlands.
Academic Medical Center, Department of Orthopaedic Surgery, Amsterdam, the Netherlands.
Am J Sports Med. 2018 Jun;46(7):1685-1692. doi: 10.1177/0363546518764916. Epub 2018 Apr 6.
Treatment of osteochondral talar defects (OCDs) after failed previous surgery is challenging. Promising short-term results have been reported with use of a metal resurfacing inlay implant.
To evaluate the midterm clinical effectiveness of the metal implant for OCDs of the medial talar dome after failed previous surgery.
Case series; Level of evidence, 4.
We prospectively studied all patients who met the inclusion criteria and received a metal resurfacing inlay implant between 2007 and 2014. The primary outcome measure was implant survival, as measured by reoperation rate. Secondary outcome measures were numeric rating scales for pain at rest and during walking, running, and stair climbing; the Foot and Ankle Outcome Score (FAOS); the American Orthopaedic Foot and Ankle Society Ankle Hindfoot Scale; the 36-Item Short Form Health Survey (SF-36); return to work and sports; and radiographic evaluation.
This study included 38 patients with a mean age of 39 years (SD, ±13 years) and a mean follow-up of 5.1 years (SD, ±1.5 years). Two patients (5%) underwent revision surgery by means of an ankle arthrodesis (2 and 6 years postoperatively). In 8 patients, computed tomography scanning was conducted to assess postoperative complaints. These scans showed impression of the tibial plafond (n = 4), a small tibial cyst (<2.5 mm; n = 1), and cyst formation around the implant screw (n = 4). A total of 21 reoperations were performed, including medial malleolar screw removal (n = 12), arthroscopic removal of bony anterior impingement (n = 7), and calcaneal realignment osteotomy (n = 2). All secondary outcome measures improved significantly, apart from pain at rest, the FAOS symptoms subscale, and the SF-36 mental component scale. The mean time for return to sport was 4.1 months (SD, ±3 months), and 77% of patients resumed sporting activities postoperatively. Only 1 patient did not return to work postoperatively. Radiographs at final follow-up showed cyst formation (n = 2), subchondral periprosthetic radiolucency (n = 2), and non-preexisting joint space narrowing (n = 2).
This study shows that the metal implant is an effective technique when assessed at midterm follow-up for OCDs of the medial talar dome after failed previous surgery.
既往手术失败后的距骨骨软骨损伤(OCDs)的治疗具有挑战性。使用金属表面置换镶嵌植入物已报道了有前景的短期结果。
评估金属植入物治疗既往手术失败后内侧距骨穹隆 OCDs 的中期临床效果。
病例系列;证据水平,4 级。
我们前瞻性地研究了所有符合纳入标准并于 2007 年至 2014 年间接受金属表面置换镶嵌植入物的患者。主要结局测量指标为再手术率,即植入物存活率。次要结局测量指标为静息和行走、跑步和爬楼梯时疼痛的数字评分量表、足踝结局评分(FAOS)、美国矫形足踝协会踝关节后足评分、36 项简短健康调查问卷(SF-36)、重返工作和运动以及影像学评估。
本研究共纳入 38 例患者,平均年龄 39 岁(SD,±13 岁),平均随访时间为 5.1 年(SD,±1.5 年)。2 例患者(5%)接受踝关节融合术行翻修手术(术后 2 年和 6 年)。8 例患者行 CT 扫描以评估术后并发症。这些扫描显示胫骨平台的压痕(n=4)、小的胫骨囊肿(<2.5mm;n=1)和植入物螺钉周围的囊肿形成(n=4)。共进行了 21 次再手术,包括内侧踝螺钉取出(n=12)、关节镜下骨前撞击去除(n=7)和跟骨矫正截骨术(n=2)。除静息时疼痛、FAOS 症状亚量表和 SF-36 心理成分量表外,所有其他次要结局测量指标均显著改善。重返运动的平均时间为 4.1 个月(SD,±3 个月),77%的患者术后恢复运动。仅有 1 例患者术后未重返工作岗位。末次随访时的 X 线片显示囊肿形成(n=2)、假体周围软骨下透亮区(n=2)和非原有关节间隙变窄(n=2)。
本研究表明,在既往手术失败后内侧距骨穹隆 OCDs 的中期随访中,金属植入物是一种有效的治疗方法。